Advisors Asset Management, Inc. Haleon PLC Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$8.02 - $8.67 $6,969 - $7,534	-869 Reduced 4.18%	19,929 $169,000
Q4 2023 Feb 14, 2024	SELL	$7.78 - $8.62 $157,210 - $174,184	-20,207 Reduced 49.28%	20,798 $171,000
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $254,956 - $285,399	-31,711 Reduced 43.61%	41,005 $343,000
Q1 2023 May 12, 2023	SELL	$7.57 - $8.37 $200,385 - $221,562	-26,471 Reduced 26.69%	72,716 $591,000
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.06 $145,406 - $196,639	-24,397 Reduced 19.74%	99,187 $793,000
Q3 2022 Nov 08, 2022	BUY	$5.63 - $7.5 $695,777 - $926,880	123,584 New	123,584 $753,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.